Skip to main content

Genetic heritage

Genetic heritage from the Stone Age protects against today's chronic inflammatory bowel diseases


In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has been rising steadily in recent decades. However, a small proportion of the European population carries a genetic variant that provides natural protection against IBD.

A newly published study in the journal eBioMedicine explores how this protective variant can be leveraged to develop modern therapies, demonstrating the potential of evolutionary medicine in addressing chronic diseases of the modern era.

The study, led by the Institute of Clinical Molecular Biology (IKMB) at Kiel University, brought together researchers from genetics, medicine, and archaeology.

"We have demonstrated that this gene variant, which offers protection against inflammatory bowel diseases, was prevalent among the first sedentary farmers in Anatolia and was introduced to Europe through ancient migration movements," explains Prof. Dr. Ben Krause-Kyora from the IKMB, lead author of the study.

The study, part of the ROOTS and "Precision Medicine for Chronic Inflammatory Diseases" (PMI) Clusters of Excellence, analyzed genetic data from 251 human genomes spanning the past 14,000 years across Europe and Anatolia. The researchers focused specifically on the IL23R gene, which plays a key role in immune regulation.

"The exact causes of chronic inflammatory bowel diseases remain unknown. However, previous research has shown that strong immune responses regulated by IL23R are closely linked to these conditions. A reduced function of this pathway appears to provide protection against chronic inflammation," explains Professor Krause-Kyora.


The IL23R variant examined in the study moderates the immune response, preventing excessive inflammation without compromising overall immune function. As a result, individuals carrying this gene variant remain largely protected from infections.

"It's a win-win situation for the body," says co-author Prof. Dr. Dr. Stefan Schreiber, spokesperson for PMI and clinical partner of the research team as a gastroenterologist at the University Medical Center Schleswig-Holstein.

About 10,000–12,000 years ago, approximately 18% of individuals in Anatolian farming communities carried this gene variant. The shift from a Paleolithic lifestyle of hunting and gathering to Neolithic farming likely triggered more frequent inflammatory reactions in individuals.

The researchers hypothesize that the IL23R variant provided protection against this heightened inflammatory status, enhancing survival among the first Neolithic farmers. This could explain its high prevalence in early agrarian societies.

From the Neolithic period onward, migratory movements gradually spread the IL23R variant across Europe over the past 8,000 years. Subsequent population admixture led to its highest prevalence in Southwestern Europe and lowest in Northeastern Europe. Interestingly, this distribution mirrors the regional prevalence of IBD, which is most common in Northern and Eastern Europe. Today, approximately 5% of the European population still carries the variant.

The study sheds light on the history of a gene variant that remains medically significant today. "We now understand why a reduced function of IL23R provides protection against inflammatory conditions. The mechanism by which this variant prevents chronic inflammatory bowel diseases has recently been applied in the development of IBD medications.

"These treatments are considered highly effective with minimal side effects. This example illustrates how we can draw inspiration from nature to develop new therapies," says Schreiber.

genetic heritage, DNA ancestry, inherited traits, genetic lineage, genealogical DNA, ancestral origins, hereditary diseases, genetic diversity, evolutionary genetics, gene expression, family genetics, mitochondrial DNA, Y-chromosome lineage, population genetics, epigenetics, genomic inheritance, biological ancestry, autosomal DNA, genetic markers, personalized genomics

#GeneticHeritage #DNAAncestry #InheritedTraits #GeneticLineage #Genealogy #AncestralOrigins #HereditaryDiseases #GeneticDiversity #EvolutionaryGenetics #GeneExpression #FamilyGenetics #MitochondrialDNA #YChromosome #PopulationGenetics #Epigenetics #GenomicInheritance #BiologicalAncestry #AutosomalDNA #GeneticMarkers #PersonalizedGenomics

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 

Comments

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...